Marine oils for antiinflammatory effect - Time to take stock

Journal of Rheumatology

Volumn 33, Issue 2, 2006, Pages 207-209

  Cleland, Leslie G ^a   James, Michael J ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; FISH OIL; MARINE OIL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; SEAL OIL; UNCLASSIFIED DRUG;

ARTHRALGIA; CARDIOVASCULAR DISEASE; DRUG EFFECT; EDITORIAL; GASTROINTESTINAL TOXICITY; HUMAN; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SEAL; UNSPECIFIED SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; SEALS, EARLESS;

EID: 32144456366     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (34)

1. Madland TM, Björkkjaer T, Brunborg LA, Fröyland L, Berstad A, Brun JG. Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil: a pilot study with double blind comparison with soy oil. J Rheumatol 2006;33:307-10.
2. Arslan G, Brunborg LA, Froyland L, et al. Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids 2002;37:935-40.
3. Bjorkkjaer T, Brunborg LA, Arslan G, et al. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand J Gastroenterol 2004;39:1088-94.
4. Howland M. Incorporation of eicosapentaenoic acid from three forms of fish oil into human blood cells [honours thesis]. Flinders University of South Australia; 1991.
5. Cleland LG, James MJ, Proudman SM. The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003;63:845-53.
6. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57.
7. Solomon DH. Selective cyclooxygenase 2 inhibitors and cardiovascular events. Arthritis Rheum 2005;52:1968-78.
8. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005;330:1366.
9. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000;71 Suppl:343S-8S.
10. Demasi M, Cleland LG, Cook-Johnson RJ, Caughey GE, James MJ. Effects of hypoxia on monocyte inflammatory mediator production: dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis. J Biol Chem 2003; 278:38607-16.
11. Belch JJF, Ansell D, Madhok R, O'Dowd A, Sturrock RD. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind controlled study. Ann Rheum Dis 1988;47:96-104.
12. National Prescribing Service. Elevated cardiovascular risk with NSAIDs? Available at: http://www.npsradar.org.au/site.php7page=1&content=/npsradar/ content/nsaids.html. Accessed December 6, 2005.
13. Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334:1557-60.
14. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med 1994;331:1194-9.
15. Lands WEM. Biosynthesis of prostaglandins. Annu Rev Nutr 1991;11:41-60.
16. Moncada S. Prostacyclin and arterial wall biology. Arteriosclerosis 1982;2:193-207.
17. Cheng Y, Austin SC, Rocca B, et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002; 296:539-41.
18. Hawkes JS, James MJ, Cleland LG. Separation and quantification of PGE3 following derivatization with panacyl bromide by high pressure liquid chromatography with fluorometric detection. Prostaglandins 1991;42:355-68.
19. von Schacky C, Fischer S, Weber PC. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 1985;76:1626-31.
20. De Caterina R, Giannessi D, Mazzone A, et al. Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery. Circulation 1990;82:428-38.
21. Catella-Lawson F, McAdam B, Morrison BW, et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 1999;289:735-41.
22. McAdam BF, Catella-Lawson F, Mardini IA, et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999;96:272-7.
23. Caughey GE, Cleland LG, Penglis PS, Gamble JR, James MJ. Roles of cyclooxygenase (COX) -1 and -2 in prostanoid production by human endothelial cells: selective upregulation of prostacyclin synthesis by COX-2. J Immunol 2001;167:2831 -8.
24. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002;20:1493-9.
25. Leaf A. The electrophysiological basis for the antiarrhythmic actions of polyunsaturated fatty acids. Eur Heart J Suppl 2001;3 Suppl D:D98-105.
26. GISSI Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55.
27. Nestel P, Shige H, Pomeroy S, et al. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 2002;76:326-30.
28. Ciubotaru I, Lee YS, Wander RC. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem 2003;14:513-21.
29. Harris W. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65 Suppl:1645S-54S.
30. Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC. Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005;165:725-30.
31. Willett WC. Fish balancing health risks and benefits. Am J Prev Med 2005;29:320-1.
32. Foods Standards Australia and New Zealand. Dioxins in food. Dietary exposure and risk characterisation. Technical Report Series 27. Available at: http://www.foodstandards.gov.au/mediareleases publications/publications/ dioxinsinfooddietaryexposureassessme tandriskcharacterisation/index.cfm. Accessed December 6, 2005.
33. UK Food Safety Authority. 26/02 June 2002. Dioxin and dioxin-like PCBs in fish oil supplements. Available at: http://www.food.gov.uk/multimedia/pdfs/ 26diox.pdf. Accessed December 6, 2005.
34. Angell M. The truth about drug companies. Melbourne: Scribe Publications; 2005.